Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Roula Farah et al.|Journal of Clinical Oncology|2016Cited by 867
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Vijay Ramaswamy et al.|Journal of Clinical Oncology|2013Cited by 488
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna Guerreiro Stücklin, Nataliya Zhukova, Scott Ryall et al.|Nature Communications|2019Cited by 372
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade GliomasÁlvaro Lassaletta, Bev Wilson, Michal Zápotocký et al.|Journal of Clinical Oncology|2017Cited by 345
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesClaire Sun, Chris Jones, Paul Daniel et al.|Cancer Cell|2023Cited by 69